A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again.

A recent poll found 1 in 8 adults take a GLP-1 medication like Ozempic or Wegovy and 27 percent of those users said even ...

While taking a GLP-1, certain behaviours can worsen side effects or inhibit the benefits you receive. Here's what to avoid.

Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

The U.S. Food and Drug Administration is asking Eli Lilly and Company, the leading manufacturer of GLP-1s, for additional ...

As more customers seek support for weight management and overall health, Walmart is expanding its Better Care Services platform with new offerings that bring together virtual care ...

What to keep in mind if you're concerned about access to your medication.

Insurance coverage for GLP-1 medications like Ozempic and Wegovy varies widely depending on the condition and your plan.

The weight loss drugs are impacting the restaurant behavior of consumers in different ways, and sometimes it divides along ...

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...

Shayla Talei's inability to eat without pain caused her to lose about 100 lbs. over the course of months before she was ...